MK-677 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MK-677 (Ibutamoren Mesylate) is researched primarily for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density. The only oral GH secretagogue producing clinically significant GH elevation without injections — uniquely accessible and practical compared to every other peptide that requires subcutaneous administration. It belongs to the Non-peptide ghrelin receptor agonist, growth hormone secretagogue category of compounds.
What Is MK-677?
MK-677 (Ibutamoren Mesylate) is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Synthetic non-peptide compound developed by Merck as an oral GH secretagogue alternative to injectable GHRPs.
The only oral GH secretagogue producing clinically significant GH elevation without injections — uniquely accessible and practical compared to every other peptide that requires subcutaneous administration. It has attracted significant research interest for its potential effects on oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
How Does MK-677 Produce These Benefits?
Selective non-peptide agonist of the ghrelin receptor (GHS-R1a) that increases GHRH production while simultaneously reducing somatostatin (GH inhibitor). Increases GH pulse amplitude and frequency, producing sustained IGF-1 elevation through enhanced endogenous GH secretion. Uniquely oral bioavailable with ~24-hour half-life enabling once-daily dosing.
This multi-pathway activity is why MK-677 shows potential across several different applications rather than being limited to a single use case.
Can MK-677 Help With Oral Gh Elevation (Up To 97% Increase)?
Research suggests MK-677 may support oral GH elevation (up to 97% increase) through its non-peptide ghrelin receptor agonist, growth hormone secretagogue activity. 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
Protocols targeting oral GH elevation (up to 97% increase) typically use 10-25 mg daily administered once daily (usually before bed) for 8-16 weeks; minimum 10-week break between cycles.
Can MK-677 Help With Lean Muscle Mass Gain?
Research suggests MK-677 may support lean muscle mass gain through its non-peptide ghrelin receptor agonist, growth hormone secretagogue activity. 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
Protocols targeting lean muscle mass gain typically use 10-25 mg daily administered once daily (usually before bed) for 8-16 weeks; minimum 10-week break between cycles.
Can MK-677 Help With Fat Loss?
Research suggests MK-677 may support fat loss through its non-peptide ghrelin receptor agonist, growth hormone secretagogue activity. 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
Protocols targeting fat loss typically use 10-25 mg daily administered once daily (usually before bed) for 8-16 weeks; minimum 10-week break between cycles.
Can MK-677 Help With Improved Sleep Quality?
Research suggests MK-677 may support improved sleep quality through its non-peptide ghrelin receptor agonist, growth hormone secretagogue activity. 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
Protocols targeting improved sleep quality typically use 10-25 mg daily administered once daily (usually before bed) for 8-16 weeks; minimum 10-week break between cycles.
Can MK-677 Help With Enhanced Recovery?
Research suggests MK-677 may support enhanced recovery through its non-peptide ghrelin receptor agonist, growth hormone secretagogue activity. 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
Protocols targeting enhanced recovery typically use 10-25 mg daily administered once daily (usually before bed) for 8-16 weeks; minimum 10-week break between cycles.
Can Stacking Enhance MK-677 Benefits?
Commonly stacked with BPC-157 for accelerated recovery, or with Ipamorelin/CJC-1295 for enhanced GH pulse amplitude. The oral convenience makes it the most practical GH secretagogue for daily use.
See our MK-677 stacking guide for detailed combination protocols.
What Is the Bottom Line on MK-677 Benefits?
MK-677 is researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density. The evidence base includes: 30+ human clinical studies document dose-dependent GH and IGF-1 elevation. Trials show improved body composition, sleep quality, and recovery markers. Phase II studies completed but FDA approval was never pursued. The most extensively human-studied oral GH secretagogue.
MK-677 is not fda-approved. not a controlled substance but banned by wada and dod. sold as research chemical. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
MK-677 (Ibutamoren): The Oral GH Secretagogue
Related Reading
- MK-677 Dosage Guide
- MK-677 Side Effects
- MK-677 Stacking Guide
- MK-677 Cycle Guide
- MK-677 Research
- BPC-157 Complete Guide
Calculate Your MK-677 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MK-677.
Open Calculator →Research-Grade Sourcing
If you're going to research MK-677, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MK-677?
MK-677 (Ibutamoren Mesylate) is a Non-peptide ghrelin receptor agonist, growth hormone secretagogue. Synthetic non-peptide compound developed by Merck as an oral GH secretagogue alternative to injectable GHRPs. It is researched for oral GH elevation (up to 97% increase), lean muscle mass gain, fat loss, improved sleep quality, enhanced recovery, bone density.
What is the recommended MK-677 dosage?
Common dosages: 10-25 mg daily administered once daily (usually before bed) via oral. Cycle length: 8-16 weeks; minimum 10-week break between cycles. Half-life: approximately 24 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of MK-677?
Increased appetite (primary side effect), water retention, lethargy, joint pain, elevated prolactin. Insulin resistance with long-term use — monitor fasting glucose. Carpal tunnel syndrome reported at higher doses. Generally well-tolerated but requires metabolic monitoring.
Is MK-677 safe?
MK-677 has shown a favorable safety profile in research. Not FDA-approved. Not a controlled substance but banned by WADA and DoD. Sold as research chemical. All research should follow appropriate safety protocols.